Evaluation of the Sensititre MycoTB plate for susceptibility testing of the Mycobacterium tuberculosis complex against first- and second-line agents.
about
First evaluation of drug-resistant Mycobacterium tuberculosis clinical isolates from Congo revealed misdetection of fluoroquinolone resistance by line probe assay due to a double substitution T80A-A90G in GyrAQuantitative drug-susceptibility in patients treated for multidrug-resistant tuberculosis in Bangladesh: implications for regimen choice.A Comparison of the Sensititre MycoTB Plate, the Bactec MGIT 960, and a Microarray-Based Molecular Assay for the Detection of Drug Resistance in Clinical Mycobacterium tuberculosis Isolates in Moscow, RussiaComparison of TaqMan(®) Array Card and MYCOTB(TM) with conventional phenotypic susceptibility testing in MDR-TB.Undertreated HIV and drug-resistant tuberculosis at a referral hospital in Irkutsk, SiberiaSensititre MycoTB plate compared to Bactec MGIT 960 for first- and second-line antituberculosis drug susceptibility testing in Tanzania: a call to operationalize MICs.Plasma drug activity in patients on treatment for multidrug-resistant tuberculosisUnderstanding pharmacokinetics to improve tuberculosis treatment outcome.Discordance across several methods for drug susceptibility testing of drug-resistant Mycobacterium tuberculosis isolates in a single laboratory.Application of quantitative second-line drug susceptibility testing at a multidrug-resistant tuberculosis hospital in Tanzania.Design, development, drug-likeness, and molecular docking studies of novel piperidin-4-imine derivatives as antitubercular agents.Assessment of a 96-Well Plate Assay of Quantitative Drug Susceptibility Testing for Mycobacterium Tuberculosis Complex in China.Artificial Intelligence and Amikacin Exposures Predictive of Outcomes in Multidrug-Resistant Tuberculosis Patients.Sensititre MYCOTB MIC plate for testing Mycobacterium tuberculosis susceptibility to first- and second-line drugsA Review of Moxifloxacin for the Treatment of Drug-Susceptible Tuberculosis.Evolution of Phenotypic and Molecular Drug Susceptibility Testing.The validation of Cycloserine efficacy in treatment of multidrug-resistant and extensively drug-resistant tuberculosis in Beijing, China.Linking minimum inhibitory concentrations to whole genome sequence-predicted drug resistance in Mycobacterium tuberculosis strains from Romania.Drug susceptibility testing of slowly growing non-tuberculous mycobacteria using slomyco test-system
P2860
Q28538008-FDC69F2F-074A-48C1-A217-07057953E783Q28543642-0BCC6614-00E5-4D3F-BE33-002F7DFC551EQ28554618-7F9CFC63-5E57-4A68-B03F-85A36F374D08Q30276393-75E5F736-1BA4-48A2-B1EA-96070F350586Q30277708-62FF8DEE-443B-43C2-84CB-0BCBF217816FQ30278816-7BE2B3FE-8900-4298-8B5F-D7F421FFC0FCQ30411475-32586230-4B9E-45E4-83CA-4CAA8C9F4CF0Q30411703-565D358A-6526-4294-8D45-66DAFB988D7DQ30414792-DF9F64DF-4A6B-4FD7-AAFD-57DFB24037A3Q30415943-A9DC4DE8-CC58-4559-8AF0-7BF3E770DC2EQ35892439-0214ECA2-D028-475D-BFB7-32932DF4E588Q36247548-488EE1FA-70D7-4839-8F26-28F5996723A4Q37287787-C56229E0-6173-4032-8F14-82794916850FQ37544293-4F2BE9A6-43D4-4852-8F72-06FD3D9BBE18Q39456569-92F5AC43-BAD2-410F-AA5E-293B405B7F59Q47632774-7E2EC254-9FE9-48C0-AEE9-99C958330A8AQ50134159-9A5238AE-1AA1-45B5-A003-FDF672A1E19AQ55424405-88CDC7B1-CA95-44B3-8FD8-3224E71937D6Q58734834-CB01F1B5-A2B0-40E2-BA2D-52391FC82C2C
P2860
Evaluation of the Sensititre MycoTB plate for susceptibility testing of the Mycobacterium tuberculosis complex against first- and second-line agents.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Evaluation of the Sensititre M ...... first- and second-line agents.
@en
type
label
Evaluation of the Sensititre M ...... first- and second-line agents.
@en
prefLabel
Evaluation of the Sensititre M ...... first- and second-line agents.
@en
P2093
P2860
P356
P1476
Evaluation of the Sensititre M ...... first- and second-line agents.
@en
P2093
Kim Dionne
Kurt P Jude
Leslie Hall
Nancy L Wengenack
Nicole M Parrish
Ryan Merson
Shirley L Clark
P2860
P304
P356
10.1128/JCM.02048-12
P407
P577
2012-08-15T00:00:00Z